Skip to main content

Oncology Advances

 

Featured Content |Content Library

Movie Release Prompts National Conversation About Colorectal Cancer in the Black Community News

Movie Release Prompts National Conversation About Colorectal Cancer in the Black Community

Dana-Farber Cancer Institute is encouraging a public dialogue to raise awareness about colorectal cancer disparities by race and ethnicity, and the importance of screening for colorectal cancer, the third most common cancer among men and ...

Study Finds That Patients With Cancer and a Suppressed Immune System are at High Risk for Severe COVID if Treated With Systemic Drug Therapies News

Study Finds That Patients With Cancer and a Suppressed Immune System are at High Risk for Severe COVID if Treated With Systemic Drug Therapies

Patients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than those who haven't received such therapies in the three months before their COVID diagnosis, show findings ...

Advancing New Treatments for Uncommon Cancer Subtypes News

Advancing New Treatments for Uncommon Cancer Subtypes

The biology of rare cancers is poorly understood in part because the tumors are uncommon, which makes them challenging to study. Clinical trials examining rare cancers are difficult.

Research Updates - Metastatic Breast Cancer Symposium

Research Updates - Metastatic Breast Cancer

In the following videos, faculty from Dana-Farber Cancer Institute review research updates from the 2022-2023 EMBRACE Metastatic Breast Cancer Patient Forum Series.

Dana-Farber’s Kornelia Polyak Elected to the National Academy of Medicine News

Dana-Farber’s Kornelia Polyak Elected to the National Academy of Medicine

Kornelia Polyak, M.D., Ph.D., professor of medicine, medical oncology, Dana-Farber Cancer Institute has been elected to the prestigious National Academy of Medicine.

In Memoriam: Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber’s Adult Oncology Program News

In Memoriam: Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber’s Adult Oncology Program

The Dana-Farber community mourns the passing of Arthur T. Skarin, MD, of Needham, Massachusetts.